Rhythm Pharmaceuticals, Inc. (RYTM) Profit Margins
Over the twelve months to 2026-06-30, Rhythm Pharmaceuticals, Inc. (RYTM) had gross margin 89.0%, operating margin -83.6%, net margin -85.6%, free cash flow margin -44.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RYTMRhythm Pharmaceuticals, Inc.Follow RYTM — free
—
Price chart with a free account
- Market cap
- 6.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 81.0% | 91.0% | 88.0% | 89.7% | 89.7% | 89.0% | |
| Operating margin | -5391.9% | -757.9% | -238.1% | -204.0% | -101.2% | -83.6% | |
| Net margin | -2207.1% | -766.2% | -238.5% | -200.3% | -103.6% | -85.6% | |
| FCF margin | -4642.9% | -734.9% | -175.9% | -87.5% | -61.5% | -44.3% |
USD millions · SEC XBRL
Rhythm Pharmaceuticals, Inc. — questions
- What is Rhythm Pharmaceuticals, Inc.'s gross margin?
- 89.0% over the twelve months to 2026-06-30.
- What is Rhythm Pharmaceuticals, Inc.'s operating margin?
- -83.6% over the twelve months to 2026-06-30.
- What is Rhythm Pharmaceuticals, Inc.'s net profit margin?
- -85.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Rhythm Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.